Caris Life Sciences (CAI) Other Non-Current Liabilities (2024 - 2026)

Caris Life Sciences' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $43.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $43.6 million; the TTM figure through Mar 2026 stood at $43.6 million (changed N/A YoY), while the FY2025 annual figure was $42.4 million, down 53.75% from the prior year.
• Other Non-Current Liabilities was $43.6 million for Q1 2026 at Caris Life Sciences, up from $42.4 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $91.6 million in Q4 2024 to a low of $42.4 million in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $59.2 million across 3 years, with a median of $43.6 million in 2026.
• Biggest YoY gain for Other Non-Current Liabilities was 53.75% in 2025; the steepest drop was 53.75% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $91.6 million in 2024, then tumbled by 53.75% to $42.4 million in 2025, then climbed by 2.86% to $43.6 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $43.6 million (Q1 2026), $42.4 million (Q4 2025), and $91.6 million (Q4 2024), per Business Quant data.